Tarng DC - Search Results

1

Iron Therapy in Chronic Kidney Disease: Days of Future Past.

Lee KH, Ho Y, Tarng DC. Lee KH, et al. Among authors: tarng dc. Int J Mol Sci. 2021 Jan 20;22(3):1008. doi: 10.3390/ijms22031008. Int J Mol Sci. 2021. PMID: 33498292 Free PMC article. Review.

2

Cardiorenal anemia syndrome in chronic kidney disease.

Tarng DC. Tarng DC. J Chin Med Assoc. 2007 Oct;70(10):424-9. doi: 10.1016/S1726-4901(08)70031-5. J Chin Med Assoc. 2007. PMID: 17962140 Free article. Review.

3

Effect of add-on direct renin inhibitor aliskiren in patients with non-diabetes related chronic kidney disease.

Li SY, Chen YT, Yang WC, Tarng DC, Lin CC, Yang CY, Liu WS. Li SY, et al. Among authors: tarng dc. BMC Nephrol. 2012 Aug 23;13:89. doi: 10.1186/1471-2369-13-89. BMC Nephrol. 2012. PMID: 22917002 Free PMC article.

4

The benefits of estrogen or selective estrogen receptor modulator on kidney and its related disease-chronic kidney disease-mineral and bone disorder: osteoporosis.

Lee WL, Cheng MH, Tarng DC, Yang WC, Lee FK, Wang PH. Lee WL, et al. Among authors: tarng dc. J Chin Med Assoc. 2013 Jul;76(7):365-71. doi: 10.1016/j.jcma.2013.03.010. Epub 2013 May 9. J Chin Med Assoc. 2013. PMID: 23664736 Free article. Review.

5

Volume overload correlates with cardiovascular risk factors in patients with chronic kidney disease.

Hung SC, Kuo KL, Peng CH, Wu CH, Lien YC, Wang YC, Tarng DC. Hung SC, et al. Among authors: tarng dc. Kidney Int. 2014 Mar;85(3):703-9. doi: 10.1038/ki.2013.336. Epub 2013 Sep 11. Kidney Int. 2014. PMID: 24025647 Free article.

6

Erythropoiesis-stimulating agents in chronic kidney disease: what have we learned in 25 years?

Hung SC, Lin YP, Tarng DC. Hung SC, et al. Among authors: tarng dc. J Formos Med Assoc. 2014 Jan;113(1):3-10. doi: 10.1016/j.jfma.2013.09.004. Epub 2013 Oct 3. J Formos Med Assoc. 2014. PMID: 24090633 Free article. Review.

7

Renoprotective effect of renin-angiotensin-aldosterone system blockade in patients with predialysis advanced chronic kidney disease, hypertension, and anemia.

Hsu TW, Liu JS, Hung SC, Kuo KL, Chang YK, Chen YC, Hsu CC, Tarng DC. Hsu TW, et al. Among authors: tarng dc. JAMA Intern Med. 2014 Mar;174(3):347-54. doi: 10.1001/jamainternmed.2013.12700. JAMA Intern Med. 2014. PMID: 24343093

8

Anaemia management in patients with chronic kidney disease: Taiwan practice guidelines.

Hung SC, Kuo KL, Tarng DC, Hsu CC, Wu MS, Huang TP. Hung SC, et al. Among authors: tarng dc. Nephrology (Carlton). 2014 Dec;19(12):735-9. doi: 10.1111/nep.12332. Nephrology (Carlton). 2014. PMID: 25156587 Review.

9

ESA and iron therapy in chronic kidney disease: a balance between patient safety and hemoglobin target.

Hung SC, Tarng DC. Hung SC, et al. Among authors: tarng dc. Kidney Int. 2014 Oct;86(4):676-8. doi: 10.1038/ki.2014.179. Kidney Int. 2014. PMID: 25265951 Free article.

10

Iron supplementation associates with low mortality in pre-dialyzed advanced chronic kidney disease patients receiving erythropoiesis-stimulating agents: a nationwide database analysis.

Kuo KL, Hung SC, Liu JS, Chang YK, Hsu CC, Tarng DC. Kuo KL, et al. Among authors: tarng dc. Nephrol Dial Transplant. 2015 Sep;30(9):1518-25. doi: 10.1093/ndt/gfv085. Epub 2015 Mar 31. Nephrol Dial Transplant. 2015. PMID: 25829323

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

300 results

Search Page

Filters